Table 2.
Grade ≥ 3 Toxicities Generally Associated With Bevacizumab During the 9-Month Period Beginning 3 Months After Completion of All Therapy
Toxicity | mFF6 | mFF6+Bev |
---|---|---|
Hypertension | 0.6 | 0.7 |
Pain | 1.1 | 1.1 |
Proteinuria | 0.1 | 0 |
ATE | 0.1 | 0.5 |
VTE | 0.4 | 0.2 |
Hemorrhage | 0.3 | 0.3 |
Abbreviations: ATE, arterial thrombotic event; mFF6, modified fluorouracil, leucovorin, and oxaliplatin for 6 months; mFF6 + Bev, mFF6 for 6 months plus bevacizumab for 12 months; VTE, venous thrombotic event.